Blood and plasma protein biomarker analysis
Protein analysis services for blood and plasma proteomics in preclinical and clinical drug development.
Push the limits of plasma proteomics
Blood and plasma proteomics require complex depletion procedures for mass spectrometry to analyze proteins present at levels below the abundant albumin.
Our affinity-based blood and plasma proteomics, using antibodies or DNA aptamers to detect proteins, provides a powerful tool to explore a broader concentration range, process hundreds of samples simultaneously, and increase exploratory depth.
GLP and GCLP compliant laboratory
We are accredited for Good Laboratory Practice (GLP) by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC) for qPCR, dPCR, and molecular biology. In addition, we are Good Clinical Laboratory Practice (GCLP) compliant to ensure the safe and reliable analysis of clinical samples.
Resources
Overview of bioanalysis in advanced therapies
- Assay design and validation
- Regulatory guidelines (EMA and FDA)
- Challenges and best practices
Genomic biomarker analysis (DNA, RNA, miRNA, ctDNA etc,)
- Technology overview
- Analytical validation
- Regulatory overview
Capability PDF
Download our latest brochure for a summary of our molecular CRO services and capabilities.